🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the reactogenicity, safety and imm...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2019-10-25
Trial ID
NCT04006808
Treatments Being Tested
The purpose of this study is to evaluate the protective effect, safety and ...
Status
Completed
Location
Xiangcheng County Center for Disease Control and Prevention
Start Date
2016-08
Trial ID
NCT02981836
Treatments Being Tested
LA rVSVΔG-ZEBOV-GP -02-PED is a Phase 1/2, randomized, controlled open labe...
Status
Completed
Location
Centre de Recherches Médicales de Lambaréné
Start Date
2021-04-09
Trial ID
NCT05130398
The goal of this clinical trial is to assess the safety and immunogenicity ...
Status
Completed
Location
CenExel RCA
Start Date
2023-05-26
Trial ID
NCT05871541
Treatments Being Tested
The purpose of this study is to assess immune response and safety of variou...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-03
Trial ID
NCT05084508
Treatments Being Tested
The purpose of this study is to evaluate the safety of a live attenuated va...
Status
Completed
Location
Xiangcheng County Center for Disease Control and Prevention
Start Date
2016-04
Trial ID
NCT02965404
Primary objective: To describe the safety profile of a second dose of ProQu...
Status
Completed
Location
Multiple Locations
Start Date
2007-10-24
Trial ID
NCT00560755
Treatments Being Tested
This an open phase Ⅳ clinical trial of live attenuated varicella vaccines m...
Status
Enrolling By Invitation
Location
Xiangcheng County Center for Disease Control and Prevention
Start Date
2021-12-18
Trial ID
NCT05095701
Treatments Being Tested
The purpose of this study is to evaluate consistency in terms of the immune...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-11-09
Trial ID
NCT01702428
Treatments Being Tested
The purpose of this study is to assess how well-tolerated GSK's investigati...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2024-11-26
Trial ID
NCT06693895